Employee Benefit Plans (Options Outstanding by Exercise Price Range) (Details) - Officer and Employee Plans - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
| Exercise Prices (in dollars per share) | $ 15.05 | $ 15.05 |
| Number Outstanding (in shares) | 5,945 | 10,148 |
| $15.05 Exercise Price | ||
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
| Exercise Prices (in dollars per share) | $ 15.05 | |
| Number Outstanding (in shares) | 5,945 | |
| Options Outstanding, Weighted Average Remaining Life | 3 months | |
| Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 15.05 | |
| Exercisable (in shares) | 5,945 | |
| Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 15.05 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|